Fertility Services Market – Industry Share Report 2022

 Fertility Services Market

Global Fertility Services Market is expected to register a CAGR of 6.02% during the forecast period and hit USD 37,357.51 Million by 2027.

Fertility services are procedures or treatments incorporated to cure genetic and fertility issues and assist in conception. These services include Assisted Reproductive Technology (ART) methods and drugs that help single parents, infertile couples, and the Lesbian, Gay, Bisexual, and Transgender (LGBT) community in planning a family.

The declining fertility rate, technological advancements in fertility treatments, growth in the median age of first-time motherhood, and rise in obesity and the consumption of alcohol/cigarettes lead to infertility, which is eventually driving the market for fertility services. According to ESHRE, more than 25 million European Union (EU) citizens are affected by infertility. In France, reimbursement/state funding includes six IUI’s (one IUI per menstruation cycle) and four IVF treatments for women under 43 years of age. These factors support the growth of the global fertility services market.

Major Key Players:

MRFR recognizes the following companies as the Key Players in the Global Fertility Services Market— Merck KGaA, Cook Medical, Irvine Scientific Company Inc., Copper Surgical, Kitazato Cooperation, Vitrolife, Ferring B. V, Invo Bioscience, Monash IVF Group, and Care Fertility.

Segment Analysis

Global Fertility Services Market has been divided based on Underlying Cause and Treatment Type. The market, based on the underlying cause, has been segregated into male infertility and female infertility. Based on treatment type, the global fertility services market is segmented into infertility drugs and assisted reproductive technology (ART).

Regional Analysis

Global Fertility Services Market, based on region, has been divided into the american fertility services, Europe, Asia-Pacific, and the Middle East & Africa. Europe is likely to hold the largest share of the global fertility services market during the assessment period owing to the lower fertility rate, increasing obesity cases, increasing IVF tourism in Spain, and growth in the median age of motherhood. The America market is expected to register substantial growth in the market owing to the high adoption rate for IVF treatment, late pregnancies, well-established healthcare systems, and declining fertility rates. Asia-Pacific is likely to hold the third-largest share of the global fertility services market. The Middle East & Africa market is expected to witness gradual growth due to a well-developed healthcare sector and continuously declining fertility rates. For instance, according to the data mentioned by the World Bank, the fertility rate in the UAE reduced from 6.9% in 1960 to 1.7% in 2016.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Pharmaceutical Contract Manufacturing Market 2022: Size, Share, Analysis and Forecast-2027

 Pharmaceutical Contract Manufacturing Market

Pharmaceutical Contract Manufacturing Market to witness a CAGR of 6.0% to attain a value of USD 174.2 Billion by 2027 owing to the growing investment in R&D activities, asserts Market Research Future (MRFR). The pharmaceutical industry is experiencing a dynamic change. Pricing pressure, pipeline challenges, and emerging markets are redesigning the way companies operate. Pharmaceutical providers need to alter as well. Contract manufacturers that distinguish their abilities and offerings will be able to retain their customers and expand their business within the competitive market.

Drivers and Restraints Impacting the Market

Over the past few years, reliance on drugs and medicines have increased significantly. With increased demand for innovative drugs and limited number of blockbuster drugs, large pharmaceutical companies are trying to stay competitive by conducting faster drug development with corresponding cost containment. Moreover, after the regulatory approval of drug, companies are left with less time to deliver drug in the market in considerable quantity. Such factors are leading to greater outsourcing of manufacturing facilities to contract manufacturers. Influx of virtual and small startups with negligible manufacturing capacity is further propelling the market growth during the assessment period. Also, rising demand for next-generation biological therapies is opening doors for manufacturers, thereby driving the market across the globe.

On the flip side, lack of manufacturing standardization and capacity utilization of issues are some of the major factors impacting the profitability of pharmaceutical contract manufacturing organizations. Moreover, increasing lead time and logistics costs are creating skepticism among pharmaceutical companies. This is further impeding the market growth across the globe.

Major Key Players:

top 10 pharmaceutical contract manufacturing companies are Grifols International, AbbVie Inc, Catalant, Patheon Inc., Lonza AG, Boehringer Ingelheim, Vetter, S.A, Pharmaceutical Product Development, and others.

Segment Analysis

The global pharmaceutical contract manufacturing market has been segmented on the basis of type.

By mode of type, the global pharmaceutical contract manufacturing market has been segmented into finished dosage formulation market, active pharmaceutical ingredient manufacturing, and others. Among these, the active pharmaceutical ingredient manufacturing dominates the global market owing to the restructuring of the pharmaceutical industry. Regulatory development in the market will let generic drug companies manufacture and develop products for export. Improvement in pharmaceutical manufacturing capabilities along with demand for specialized technologies is considered to steer few companies to return to sourcing APIs from the suppliers.

Regional Analysis

Geographically, the pharmaceutical contract manufacturing market span across regions namely, Asia Pacific, America, Europe, and the Middle East and Africa.

Among all the regions, the American region is presumed to dominate the global market due to well-developed technology, improvement in the reimbursement scenario, high expenditure on healthcare, and the presence of major market players.

Europe is considered to hold the second position in the global pharmaceutical contract manufacturing market and is estimated to maintain its dominance over the assessment period. The growth is attributed to the support provided by the government for research and development activities in this region.

The Asia Pacific region is estimated to be the fastest growing region during the assessment period owing to the rapidly improving technology and the presence of a huge patient population in this region. However, the Middle East and Africa hold the least share in the market due to the presence of slow and poor developing countries in this region.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

AI in Drug Discovery Market Research Report- Forecast till 2030

 AI in Drug Discovery Market

The growth of the global AI in drug discovery market is driven by various factors such as investments by industry giants into the AI business, increasing number of startups operating in AI spectrum for healthcare including drug discovery, machine learning, and other AI technologies and increased use of AI technology by major pharma companies in the drug discovery.

AI in Drug Discovery Market is expected to hold a value of about USD 8.9 Billion by 2030, and it is projected to register a CAGR of 24.9% from 2022 to 2030.

In addition, the increasing number of cross-industry partnerships for achieving the common goal of improvement in the drug development outcomes is another factor for the growth of the AI in the drug discovery market. Below is the chart representing the number of AI-driven deals each of the Big Biopharma companies have disclosed till March 2019.

Major Key Players:

Players leading the global AI in drug discovery market include Microsoft Corporation, IBM Corporation, Alphabet Inc., Atomwise, Inc., Deep Genomics, Cloud Pharmaceuticals, Inc., Insilico Medicine, BenevolentAI, Exscientia, Cyclica, Bioage, Numerate, Numedii, Inc., Envisagenics, Twoxar, Incorporated, Owkin, Inc., Xtalpi, Inc., Verge Genomics, and Berg LLC, among others. 

Segment Analysis

The report is segmented into seven dynamics;

By Product Type     : Services and Software.

By Molecule Type: Large and Small Molecules.

By Technology         : Machine Learning, Deep Learning, and others.

By Indication           : Immuno-oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Metabolic Diseases, and others.

By Application         : Target Identification, Candidate Screening, De novo Drug Designing, Drug Optimization & Repurposing, Preclinical Testing, and others.

By End-User : Pharmaceutical & Biotechnology Companies, Research Centers and Academic & Government Institutes, Contract Research Organizations, and others.

By Regions                : Americas, Europe, Asia Pacific, and Rest-of-the-World. 

Regional Analysis

The artificial intelligence in medicine market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas region is expected to be the largest market owing to the number of big AI platform developers present in the region, such as Microsoft Azure, TensorFlow, and Google AI. The market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. Increasing demand for AI solutions by the pharmaceutical players such as AbbVie, Genentech, Amgen, and Eli Lilly and Company, among others, is pushing the market growth in the region. The European AI in drug discovery market is the second-largest market, and it has been categorized as Western Europe and Eastern Europe. The Western European market has further been divided as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. High demand for AI platforms and increasing integration into the drug discovery by major players such as Novartis, AstraZeneca, GSK, BI, BMS, and Sanofi, among others, are expected to drive the growth of AI in drug discovery market in the European region.

The AI in drug discovery market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to increasing R&D activities in the region and increasing adoption of the AI technologies by the pharma companies in countries like China and India, the market in Asia-Pacific is expected to grow at a significant rate during the forecast. The AI in drug discovery market in the Middle East & Africa has been divided into the Middle East and Africa.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Electric Wheelchair Market Research Report - Global Forecast till 2030

 Electric Wheelchair Market

Electric wheelchairs get power from an electric motor that comes attached with the electric wheelchair. These wheelchairs offer great mobility and are light in weight. These are very compact in size and can be used in narrow pathways. The global electric wheelchair market is expecting substantial market growth during the forecast period (2019-2023). Market Research Future (MRFR) made a claim recently that the global electric wheelchair market can surpass the existing market valuation with relative ease.

Electric Wheelchair Market size is expected to reach USD 6.47 Billion by 2030 at 6.8% CAGR during the forecast period 2022-2030.

The electric wheelchair market is expecting strong support from various pointers for a better market growth. It is expecting strong growth due to competitors participating more and more in the market to take the market ahead with their strategic moves. Its easy application is fast gaining momentum. Latest innovations are also helping the global market in its growth opportunity. However, high price and maintenance complexity can deter the global electric wheelchair market growth in the coming years.

Major Key Players:

MRFR recognizes the following companies as the Key Players in the Global Electric Wheelchair Market— GF Health Products, Inc. (US), Sunrise Medical (Germany), Quantum Rehab (US), Permobil AB (Sweden), Pride Mobility Products Corp (US), Invacare Corporation, Drive Medical (US), Ottobock (Germany), Levo AG (Switzerland), and Karman Healthcare, Inc. (US).

Segment Analysis

MRFR’s report of the global electric wheelchair market has an in-depth eye on segmentation that can impact the market in the coming years. Such a segmentation has its roots in the value-wise and volume-wise analysis of factors that can impact of the market.

Based on the electric wheelchair types, the electric wheelchair market comprises electric outdoor chair, electric indoor chair, center wheel drive chair, dual-purpose chair, front wheel drive chair, rear wheel drive chair, standing electric wheelchair, and others. The electric indoor chair segment has substantial market coverage. In many countries, lack of outdoor infrastructure can put some restraints on the expected market growth.

Based on the end-use, the electric wheelchair market comprises home care settings, hospitals/clinics, and others. The home care settings market is gaining remarkable coverage with many patients are looking for recovery from such setups.

Regional Analysis

Global Electric Wheelchair Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas has been segmented into North America and Latin America, with the North America market further divided into the US and Canada. The Americas led the market and accounted for the largest share in 2019. The technological advancement in the electric wheelchair with attachment of gadgets for control and accessibility majorly drive the market growth. Also, the rise in purchasing power, increasing geriatric population, and inclination towards more refined technology have been driving the progress of the electric wheelchair market in the region.

The European electric wheelchair market has been further segmented into Western Europe and Eastern Europe. The Western Europe electric wheelchair market has further been classified into Germany, France, the UK, Italy, Spain, and the Rest of Western Europe. Europe held the second-largest position in the electric wheelchair market with a market share of 29.3% in 2019 and anticipated to witness significant growth over the forecast period due to a higher number of patients and the availability of products in the region. Europe is also expected to have high growth in the electric wheelchair market, owing to the rising number of physically challenged people in the region.

Asia Pacific is anticipated to register the highest growth rate with a CAGR value of 8.5% over the forecast period from 2020 to 2030. According to the United Nations, across Asia, the number of people age 65 and above is expected to grow dramatically over the next 50 years. Moreover, the increasing disposable income of middle-class families, which accounts for a large population in Asia, encouraging them to spend more on health, is driving the growth of the electric wheelchairs market in the region.

The Middle East & Africa electric wheelchair market is segmented into the Middle East and Africa. The growth of the electric wheelchair market in the Middle East and Africa is growing steadily in the past few years. Increasing the prevalence of orthopedics disorders and funding by private players and government bodies is propelling the market growth in this region.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Body Composition Analyzers Market | Global Market Synopsis & Forecast – 2027

 

Body Composition Analyzers Market

According to MRFR analysis, Body Composition Analyzers Market is expected to register a CAGR of 7.6% during the forecast period.

Body composition contains three major compound water, fat mass, and muscle mass. Body composition analyzing devices are used for measuring the ratio of water, fat, and muscles in the body and recording their respective values at the point of the investigation. Body composition analyzers provide aid in analysis of increased variations in the body structure for a specific period. It has applications medical research, sports, causal association research studies in the disciplines of nutrition, anthropology, epidemiology, etc.

The growth of the global body composition analyzers market is determined by numerous factors such as increasing prevalence of metabolic disorders, technological advancements in the healthcare industry, and rising obese population. However, the increasing cost of body composition analyzers and inconsistent results are likely to hamper the growth of the global body composition analyzers market during the forecast period.

Several market players currently dominate the global body composition analyzers market. The key players are involved in product launches and strategic collaborations to strengthen their market positions.

Major Key Players:

Some of the key players in the Global Body Composition Analyzers Market are GE Healthcare Inc., Hologic Inc., Beurer GmbH, Inbody Co. Ltd., Bodystat, Cosmed S.R.L,  Jawon Medical Co., Ltd, Maltron International Ltd., Omron Healthcare Inc., Seca GmbH & Co. Kg., Tanita Corporation, AccuFitness, LLC,  and others.

Segment Analysis

The global body composition analyzers has been segmented based on best body composition analyzer product type, mobility, and end user.

The market, based on product type, has been divided into bioimpedance analyzer, skinfold calipers, dual-energy X-Ray absorptiometry, hydrostatic weighing equipment, air displacement plethysmography, and others. Bioimpedance analyzers are likely to hold the maximum market share in the global body composition analyzers market.

Based on mobility, body composition analyzers are divided into portable body composition analyzers and stationary body composition analyzers.

The end user segment of the market consists of hospitals, academic and research centers, fitness centers, home users, and others. The hospitals segment is expected to hold the largest share of the market as these centers are the primary locations for patients receiving treatment and undergoing medical procedures.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas are anticipated to hold the largest market share. The body composition analyzers market in the Americas has further been branched into North America and Latin America, with the North American market being divided into the US and Canada. Increasing obesity in population, rising awareness about fitness, and technological advancements in the healthcare sector are likely to provide favorable conditions for the growth of the market during forecast period. 

The Asia-Pacific is anticipated to be the fastest growing market owing to the rising number of chronic disorders, well-established healthcare sectors, and increasing healthcare expenditure. The body composition analyzers market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. According to the report published by International Diabetes Federation, in 2017, more than 72.94 million patients were affected by diabetes, this number represents 8.8% of the total population

The European body composition analyzers market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The body composition analyzers market in the Middle East & Africa has been divided into the Middle East and Africa.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Artificial Intelligence in Healthcare Market – Industry Share Report 2022

 Artificial Intelligence in Healthcare Market

The Healthcare Artificial Intelligence Market is expected to grow at a CAGR of 51.9% and reach USD 12 Billion by the end of the forecast period. The growing desire to reduce healthcare expenses, as well as increases in processing power and lower hardware costs, boost the healthcare artificial intelligence market. An increase in the number of collaborations and partnerships between various domains in the healthcare ecosystem, as well as a greater need to improve the quality of healthcare services as a result of the disconnect between patients and health workers.

Artificial intelligence allows doctors to use tools that help them diagnose and treat patients more accurately and quickly. However, doctors are hesitant to embrace modern technology, despite patients' increasing preference for them over in-person therapy. With this issue posing a threat to the doctor-patient connection and doctors' reluctance to use AI technology, the healthcare artificial intelligence market is likely to suffer a setback shortly.

Major Key Players:

The major key players in the market are Deep Genomics, Next IT Corp., General Vision, Google, NVIDIA Corporation, IBM Watson Health, Intel Corporation, Koninklijke Philips N.V, General Electric, Stryker, Microsoft Corporation, and CloudMedx Inc.

Segment Analysis

Based on the Component, the global ai in healthcare market has been segmented into Hardware, Software, and Services.

Based on the Application, the global Healthcare Artificial Intelligence (AI) Market has been segmented into Robot-Assisted Surgery, Virtual Nursing assistants, Dosage Error Reduction, Clinical Trial, Preliminary Diagnosis, and Automated Image Diagnosis.

Based on the Technology, the global Healthcare Artificial Intelligence (AI) Market has been segmented into Machine Learning, Querying methods, Natural Language Processing, Context-Aware Computing, and Computer Vision.

Based on the End-User, the global Healthcare Artificial Intelligence (AI) Market has been segmented into Hospital & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, and Academic & Research Laboratories.

Based on the Region, the global Healthcare Artificial Intelligence (AI) Market has been segmented into North America, Europe, Asia-Pacific, and the Rest of the World.

Regional Analysis

The Americas has the biggest AI market share in healthcare, which is predicted to continue during the forecast period. A growing biotechnology industry and increasing uses of robot-assisted surgery are two of the key factors that have propelled the Americas to the forefront. An increasing need for better diagnosis and treatment facilities, an increase in demand for digital health systems, and a substantial presence in the area of important AI inventions and product developers are all factors favoring AI in healthcare market development.

Europe is the second-largest sector, because of ongoing R&D in the healthcare AI field. The region's growth pattern is similar to that of the Americas, and the region's business growth is aided by the rapid acceptance of AI in healthcare. The Asia-Pacific region is a fast-growing market with a large number of people seeking high-quality chronic disease treatment. The healthcare sector in the region is quickly expanding due to rising spending.

Meanwhile, the Middle East and Africa would have slower growth than other regions due to a lack of specialized healthcare facilities in parts of the region. The rising healthcare artificial intelligence industry in the MEA region is predicted to have the most impact on business growth.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

EClinical Solutions Market 2022: Size, Share, Analysis and Forecast-2027

 EClinical Solutions Market

The global eClinical Solutions Market is expected to have a market value of USD 13,209.14 million by 2027.

The eClinical Solutions Market suffered immensely because pet owners and farmers were encouraged to keep their animals at home. They were advised against taking their pets to the vet to get strong and effective vaccines like the Pfizer veterinary vaccines. Growth in the veterinary/eClinical Solutions Market is starting to pick up dramatically now that a vaccine for COVID-19 is being widely administered. Demand for animal vaccines is surging because livestock on farms around the world need these to remain healthy.

Major Key Players:

Some of the key players operating in the eClinical Solutions Market are Boehringer Ingelheim International GmbH (Germany), Zoetis Inc. (US), Ceva Santé Animale (France), Merck & Co., Inc. (US), Elanco Animal Health Incorporated (US), Virbac (France), Phibro Animal Health Corporation (US), Hipra (Spain), Biogénesis Bagó S.A.(Argentina), Neogen Corporation (US).

Segment Analysis

The global animal pharmaceuticals market is segmented into type, technology, and region. The type segment is further segmented into porcine vaccines, poultry vaccines, livestock vaccines, companion animal vaccines, aquacultutre vaccines. The technology segment is segmented into Live attenuated vaccines, Inactivated vaccines, Toxoid vaccines, Recombinant vaccines, others.

Regional Analysis

The global palliative care market, based on region, has been divided into Americas, Europe, Asia-Pacific, and Middle East & Africa.

Americas dominated the global animal vaccine market due to various factors, such as the rising prevalence of animal diseases and the rise in pet ownership in the region. Furthermore, the high number of veterinary clinics in the region also boosts the growth of the market. There is an increasing prevalence of animal diseases such as foot & mouth disease, canine parvovirus, distemper, and reproductive & respiratory syndrome. Parvovirus infections are seen across the US and Canada. The American Veterinary Medical Association (AVMA) reported around 118,624 veterinary practitioners were operating in 2020. Similarly, according to the statistics published by the Canadian Veterinary Medical Association in 2020, about 12,921 veterinarians were present in Canada.

Europe accounted for a significant share in the market owing to a high population of companion animals in Europe, rising research and development investment, and increasing adoption of animal vaccines. According to the Industrial Association of Pet Care Producers, there are around 34 million pets in the UK, including dogs, cats, small mammals, and birds. In October 2021, Boehringer Ingelheim announced an additional 100 million EUR investment in its veterinary public health capabilities in Lyon-Jonage, France, to aid governments and public health organizations in managing future emerging and transboundary diseases. The additional investment will enable the adaptation of production lines for other emerging diseases, in particular swine and avian vaccines.

Asia-Pacific is expected to exhibit the highest CAGR during the forecast period of 2021-2027. This is due to lucrative opportunities for players operating in the animal vaccine market, a rise in the livestock population, and the increasing prevalence of animal diseases in the region. There is increasing awareness about animal health in the Asia-Pacific region. For instance, according to the report published by Pet Fair Asia and goumin.com, the total number of pet dogs and cats in China reached 99.15 million, with pet owners spending 29 billion US dollars in 2019. The increasing prevalence of animal diseases such as foot and mouth disease and avian influenza boosts the market growth in the region.

Middle East & Africa is expected to witness restricted growth compared to other regions due to limited access and healthcare affordability. The market growth in the region is driven by factors like the increasing incidence of zoonotic diseases and increasing pet adoption in the region. The common zoonotic disease diagnosed in this region is Rift Valley fever. Hence, emphasis is being put on promoting animal health in the region and improving healthcare services for companion animals.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Radiology Services Market Research Report- Forecast till 2027

 Radiology Services Market

The Global Radiology Services Market is accounted for USD 8,102.51 million in 2018 and expected to register 10.5% CAGR during the forecast period.

The radiology services refer to an expert consultant treating disease by choosing the proper examination, interpreting the resulting medical images, and using test results in monitoring the operations of medical care, treating diseases by using radiation or minimally invasive, image-guided therapeutic arbitration.

The increasing healthcare expenditure, prevalence of the chronic disease, technology advancement, the emergence of thin client 3D viewers, increasing demand for minimally invasive procedures are the factor driving the growth of the market. Moreover, rising spending on research and development and aggressive strategies adopted by the top players, such as new product launches, are contributing to the growth of the market. For instance, according to a research paper published by the National Center for Biotechnology Information (NCBI) in September 2016, diabetes will be the 7th leading cause of death by 2030. Also, 80% of diabetes patients live in less developed regions in the world. Increasing cases of obesity, socioeconomic transitions, and nutrition transitions are promoting the occurrence of diabetes, especially in low & middle-income countries, such as Brazil, Russia, India, China, and South Africa. Therefore, the rising prevalence of diabetes is supporting market growth.

However, high radiation exposure associated with the devices may hinder the growth of the market during the assessment period.

Major Key Players:

Some of the prominent key players in the global radiology services market are 4ways Healthcare Limited, Cybernet Medical Corporation, Everlight Radiology, Global Diagnostics, Medica Reporting Ltd., Onrad, Inc, Radisphere National Radiology Group Inc., RamSoft Inc., Siemens Healthcare, Telediagnostics Services Pvt. Ltd., Telemedicine Clinic, Teleradiology Solutions Inc, and Virtual Radiology (vRAD).

Segment Analysis

The global radiology services market has been segmented on the basis of product type, application, technology, end user, and region.

On the basis of the product type, the market has been segmented into stationary digital radiology systems and portable digital radiology systems. teleradiology services, stationary digital radiology systems have been further segmented into stationary ceiling-mounted systems and floor-to-ceiling mounted system. On the basis of the application, the market has been classified into cardiovascular imaging, chest imaging, dental imaging, mammography imaging, orthopedic imaging, and others. Based on the technology, the market has been segmented into computed radiology and direct digital radiology. On the basis of the end user, the market has been classified as hospitals, diagnostic centers, and others. The stationary digital radiology segment is likely to hold the noticeable market share of the radiology services market due to the rising demand for stationary systems in hospitals, wide application, and less radiation exposure. However, portable digital radiology segment is showing the highest growth rate during the assessment period owing to simplicity in workflow, low-cost, and proficiency performing complex computational tasks.

Regional Analysis

The market is likely to dominate by Americas during the forecast period owing to the increasing aging population, chronic disease, funding & investments, and government initiative towards advance healthcare infrastructure. The European market is expected to be the second-largest due to government funding and support of the healthcare sector coupled with increasing research and development, and favorable reimbursement policies. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to the increasing prevalence of cancer, rising investments in healthcare, and expansions by market players in the region. The market in the Middle East & Africa is likely to account for the smallest share of the global radiology services market

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Healthcare Business Intelligence Market Research Report - Global Forecast till 2027

 Healthcare Business Intelligence Market

The global healthcare business intelligence market held a market value of USD 3,650.1 million in 2017 and is projected to grow at a CAGR of 15.5% over the forecast period. Business intelligence is a set of processes, architectures, and technologies used for the collection, integration, analysis, and presentation of business information. Healthcare data analytics provides healthcare companies and hospitals to prepare, analyze & visualize big and disparate data. Factors characterizing the market growth are the worldwide surge in the number of patient registries, increasing adoption of big data in healthcare, the presence of government initiatives to increase electronic health record (EHR) adoption, and growing need to curb healthcare costs. On the contrary, the lack of skilled professionals in the Asia-Pacific and African regions along with the complexity of systems is anticipated to hinder the market growth over the forecast period.

Novel trends in the healthcare business intelligence are artificial intelligence (AI) or machine learning, data insurance or security, multi-cloud system, and advanced analytics, which is increasingly facilitating the adoption of BI in the healthcare sector. Big data analytics along with the internet of things are revolutionizing the healthcare sector in terms of health tracking, reducing healthcare associated costs, assisting high-risk patients, and preventing human errors.

Major Key Players:

Some of the foremost players in the global healthcare business intelligence market are Microsoft Corporation, International Business Machines Corporation, SAP SE, Oracle Corporation, SAS Institute, Tableau Software, MicroStrategy Incorporated, Qlik Technologies, Information Builders, Sisense, Yellowfin International Pty Ltd, and BOARD International S.A.

Segment Analysis

The business intelligence in healthcare market has been segmented into component, function, application, deployment model, end user, and region.

By component, the market has been segmented into platforms, software, and services.

On the basis of function, the market has been divided into OLAP and visualization, performance management, and query and reporting.

Based on application, the market has been categorized into financial analysis, clinical analysis, and operational analysis. The financial analysis is further categorized into claims processing, revenue cycle management, payment integrity and fraud, waste, and abuse, and risk adjustment and assessment. The clinical analysis segment is sub-segmented into quality improvement and clinical benchmarking, clinical decision support, regulatory reporting and compliance, comparative analytics/effectiveness, and precision health. The operational analysis segment is additionally divided into inventory analysis, workforce analysis, and strategic analysis.

By deployment model, the market has been divided into cloud-based, on-premise, and hybrid. On the basis of end user, the market has been categorized into payers, providers, and others.

Regional Analysis

The global healthcare business intelligence market has been segmented by region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. On the basis of region, the Americas is expected to dominate the global healthcare business intelligence market. This is due to the presence of software and service vendors, and sophisticated healthcare infrastructure, mounting adoption of data-driven decision-making, and emerging fields of prescriptive, predictive analytics.

Europe would be the second-largest region in the healthcare business intelligence market due to burgeoning healthcare vertical, increasing adoption of advanced medical technologies, and the presence of vendors such as SAP SE and BOARD International S.A.

The market in Asia-Pacific is expected to exhibit comparatively higher CAGR over the forecast period owing to increasing penetration of smartphones and internet, increasing investments in the healthcare infrastructure, rapid industrialization in India, China, and Japan, and a growing number of start-ups focusing on mobile application development.

The Middle East & Africa has the least share of the global healthcare business intelligence market. Additionally, the major market share of the region would be held by the Middle East region as the business intelligence and analytics solutions are of paramount importance to organizations in the Gulf Cooperation Council (GCC) countries.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Intracranial-Pressure Monitoring Market: Industry Trends, Segments, Analysis and Forecast – 2027

 Intracranial-Pressure Monitoring Market

The global intracranial pressure monitoring market is mainly driven by the growing demand for noninvasive tools in the field of ICP monitoring and the increasing awareness about the importance of intracranial pressure monitoring in containing and managing neural and skeletal damage.

The Global Intracranial Pressure (ICP) Monitoring Market is expected to exhibit a strong 7.1% CAGR over the forecast period, According to the latest research report from Market Research Future (MRFR).

Major Key Players:

Leading players in the global intracranial pressure monitoring market include DePuy Synthes, Terumo Corporation, Spiegelberg GmbH & Co. KG, RAUMEDIC Inc., Boston Neurosciences, Medtronic plc, Integra LifeSciences Corporation, Sophysa SA, and Natus Medical Inc.

Segment Analysis

The global intracranial pressure (ICP) monitoring market can be segmented on the basis of route of intervention, technique, device, application, end user, and region.

By route of intervention, the global intracranial pressure monitoring market is segmented into intraventricular and epidural sensor.

By technique, the market is segmented into invasive and non-invasive. The former is segmented into microtransducer ICP monitoring and external ventricular drainage (EVD), while the latter is sub-segmented into transcranial doppler ultrasonography, tympanic membrane displacement (TMD) analyzer, optic nerve sheath diameter sonography, fundoscopy (papilladema), and MRI/CT.

Devices offered in the intracranial pressure monitoring market include intraventricular catheter, subarachnoid screw, epidural sensors, and non-invasive ICP monitors.

Key applications include traumatic brain injury, intracerebral hemorrhage, subarachnoid hemorrhage, and meningitis.

Major end users of ICP monitoring include hospitals & clinics and trauma centers.

Regional Analysis

Americas held a dominant 41.4% share in the global intracranial pressure monitoring device market in 2017 and are likely to hold on to the lead in the global intracranial pressure monitoring market over the forecast period due to the increasing demand for effective intracranial pressure monitoring devices in North America. Widespread awareness about the importance of intracranial pressure monitoring in North America, particularly the U.S. and Canada, is likely to remain a major driver for the intracranial pressure monitoring market in the Americas over the forecast period. Intracranial pressure monitoring is mainly used in the management of brain trauma and skeletal hemorrhage. The rising prevalence of both these target conditions in North America is likely to remain a major driver for the intracranial pressure monitoring market in the region over the forecast period.

Europe is also likely to hold a significant share in the global intracranial pressure monitoring market over the forecast period due to the increasing awareness about the process and the relevance of the monitoring in medical diagnosis and trauma management. Intensive efforts at trauma control and management in European countries are likely to be a major driver for the intracranial pressure monitoring market in the region over the forecast period. The growing demand for noninvasive intracranial pressure monitoring tools in Europe and North America is also likely to be a major driver for the market, as the healthcare sector in these advanced regions is transitioning towards noninvasive medical tests, leading to a corresponding increase in the demand for noninvasive tools and technologies from the medical devices sector. Despite the increasing awareness about the inefficacy of noninvasive testing in intracranial pressure monitoring, the demand for product innovations aiming at making noninvasive intracranial pressure monitoring more accurate and on par with invasive monitoring is likely to remain a major driver for the intracranial pressure monitoring market in North America and Europe over the forecast period.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com